Orthofix International (OFIX) Misses Q4 EPS by 7c, Revenues Miss; Offers Q1 & FY20 EPS/Revenue Guidance Below Consensus

Go back to Orthofix International (OFIX) Misses Q4 EPS by 7c, Revenues Miss; Offers Q1 & FY20 EPS/Revenue Guidance Below Consensus

Orthofix Reports Fourth Quarter and Fiscal Year 2019 Financial Results

February 24, 2020 4:03 PM EST

Fourth Quarter Highlights

Net sales of $121.5 million, an increase of 0.3% compared to prior year period and 0.9% on a constant currency basis Kevin Kenny, an experienced spine executive, joins as Global Spine President FDA approval of next generation Bone Growth Therapy patient monitoring app STIM onTrack 2.1

Fiscal Year 2019 Highlights

Net sales of $460.0 million, an increase of 1.5% compared to prior year and 2.6% on a constant currency basis M6-C artificial disc achieves $4.1 million in sales in the US Successful transition to Jon Serbousek as... More